Improving quality of care for depression: the German Action Programme for the implementation of evidence-based guidelines.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 16260456)

Published in Int J Qual Health Care on October 31, 2005

Authors

Martin Härter1, Isaac Bermejo, Günter Ollenschläger, Frank Schneider, Wolfgang Gaebel, Ulrich Hegerl, Wilhelm Niebling, Mathias Berger

Author Affiliations

1: Department of Psychiatry and Psychotherapy, University of Freiburg, Freiburg, Germany. martin_haerter@psyallg.ukl.uni-freiburg.de

Articles by these authors

Suicide prevention strategies: a systematic review. JAMA (2005) 14.79

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet (2008) 6.24

The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev (2009) 4.35

WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry (2010) 4.26

Post-traumatic stress disorder--a diagnostic and therapeutic challenge. Dtsch Arztebl Int (2014) 3.87

Does the pharmaceutical industry influence guidelines?: two examples from Germany. Dtsch Arztebl Int (2013) 3.78

Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ (2003) 3.78

Genome-wide association study of alcohol dependence. Arch Gen Psychiatry (2009) 3.08

Conflicts of interest among authors of medical guidelines: an analysis of guidelines produced by German specialist societies. Dtsch Arztebl Int (2012) 2.78

Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull (2008) 2.59

Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med (2012) 2.52

The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial. Patient Educ Couns (2007) 2.18

Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness. Neuroimage (2003) 2.09

Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland. J Urol (2009) 2.03

Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage (2004) 1.84

Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev (2008) 1.75

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry (2009) 1.71

Declaration and Handling of Conflicts of Interest in Guidelines: A Study of S1 Guidelines From German Specialist Societies From 2010-2013. Dtsch Arztebl Int (2015) 1.68

Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int (2005) 1.55

Best practice elements of multilevel suicide prevention strategies: a review of systematic reviews. Crisis (2011) 1.55

Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci (2008) 1.55

Response and remission criteria in major depression--a validation of current practice. J Psychiatr Res (2010) 1.52

An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. Am J Psychiatry (2007) 1.50

Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program. Schizophr Res (2005) 1.48

Gender differences in the cognitive control of emotion: An fMRI study. Neuropsychologia (2007) 1.44

Catatonia in DSM-5. Schizophr Res (2013) 1.43

Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia. J Clin Psychopharmacol (2003) 1.43

Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med (2005) 1.42

Multidimensional assessment of empathic abilities: neural correlates and gender differences. Psychoneuroendocrinology (2010) 1.41

PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat (2004) 1.40

[Evidence-based treatment of depression: what does the new S3- and national healthcare guideline Unipolar Depression really recommend?]. Z Psychosom Med Psychother (2010) 1.40

Altered EEG lagged coherence during rest in obsessive-compulsive disorder. Clin Neurophysiol (2013) 1.39

Development of the interdisciplinary evidence-based s3 guideline for the diagnosis and treatment of prostate cancer: methodological challenges and solutions. Onkologie (2010) 1.39

Brain structure anomalies in autism spectrum disorder--a meta-analysis of VBM studies using anatomic likelihood estimation. Hum Brain Mapp (2011) 1.39

Prediction of psychosis by mismatch negativity. Biol Psychiatry (2010) 1.38

Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol (2011) 1.37

Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci (2004) 1.34

Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups. Gen Hosp Psychiatry (2004) 1.34

Predicting delirium after vascular surgery: a model based on pre- and intraoperative data. Ann Surg (2003) 1.33

Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety (2007) 1.32

Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res (2014) 1.32

Same or different? Neural correlates of happy and sad mood in healthy males. Neuroimage (2005) 1.30

Participation in a quality of care study and consequences for generalizability of general practice research. Fam Pract (2005) 1.29

Definition and description of schizophrenia in the DSM-5. Schizophr Res (2013) 1.28

Deformation field morphometry reveals age-related structural differences between the brains of adults up to 51 years. J Neurosci (2008) 1.25

The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases. Cancer Cytopathol (2012) 1.24

EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage (2008) 1.24

Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. Am J Psychiatry (2004) 1.24

Attenuated psychosis syndrome in DSM-5. Schizophr Res (2013) 1.24

Evidence for a close relationship between conscious effort and anterior cingulate cortex activity. Int J Psychophysiol (2004) 1.21

Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr Res (2013) 1.21

Neural correlates of working memory dysfunction in first-episode schizophrenia patients: an fMRI multi-center study. Schizophr Res (2006) 1.21

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry (2007) 1.19

Generalized deficit in all core components of empathy in schizophrenia. Schizophr Res (2008) 1.19

Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry (2005) 1.18

Structure of the psychotic disorders classification in DSM-5. Schizophr Res (2013) 1.16

Profiling of Candida albicans gene expression during intra-abdominal candidiasis identifies biologic processes involved in pathogenesis. J Infect Dis (2013) 1.16

Increased neural response related to neutral faces in individuals at risk for psychosis. Neuroimage (2007) 1.15

White-matter abnormalities in Tourette syndrome extend beyond motor pathways. Neuroimage (2010) 1.14

Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm. Psychother Psychosom (2010) 1.14

Neural correlates of emotion recognition in schizophrenia. Schizophr Res (2010) 1.14

Side effects of atypical antipsychotics: a brief overview. World Psychiatry (2008) 1.13

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord (2008) 1.13

Neuroenhancement: status quo and perspectives. Eur Arch Psychiatry Clin Neurosci (2008) 1.13

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. J Affect Disord (2010) 1.12

Automated quality assurance routines for fMRI data applied to a multicenter study. Hum Brain Mapp (2005) 1.11

Reduced early auditory evoked gamma-band response in patients with schizophrenia. Biol Psychiatry (2009) 1.11

Sound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI. Neuroimage (2005) 1.11

Screening for depression in primary care: will one or two items suffice? Eur Arch Psychiatry Clin Neurosci (2004) 1.10

Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. Schizophr Bull (2010) 1.10

Delusion of pregnancy. A case report and review of the literature. Psychopathology (2003) 1.08

Neuronal correlates of facial emotion discrimination in early onset schizophrenia. Neuropsychopharmacology (2008) 1.07

Incongruence effects in crossmodal emotional integration. Neuroimage (2010) 1.07

PKHD1 mutations in families requesting prenatal diagnosis for autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat (2004) 1.06

Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry Clin Neurosci (2009) 1.06

Modern modularity and the road towards a modular psychiatry. Eur Arch Psychiatry Clin Neurosci (2008) 1.06

Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia. J Psychiatr Res (2007) 1.06

Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays? Radiat Oncol (2011) 1.05

Deconstructing Psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophr Bull (2007) 1.05

Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology (2002) 1.05

Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage (2007) 1.04

Prediction of treatment response in major depression: integration of concepts. J Affect Disord (2006) 1.04

Single-trial coupling of EEG and fMRI reveals the involvement of early anterior cingulate cortex activation in effortful decision making. Neuroimage (2008) 1.04

[Is "Internet Addiction" a disorder of its own?--a study on subjects with excessive internet use]. Psychiatr Prax (2007) 1.04

Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry (2003) 1.04

Notification of critical results: a College of American Pathologists Q-Probes study of 121 institutions. Arch Pathol Lab Med (2008) 1.03

Disease-modifying therapies in Alzheimer's disease: how far have we come? Drugs (2006) 1.03

Differential brain activation during facial emotion discrimination in first-episode schizophrenia. J Psychiatr Res (2008) 1.03

German research network on schizophrenia-bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci (2003) 1.01

Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry (2007) 1.01

Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatr Serv (2012) 1.00

Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment. Early Interv Psychiatry (2007) 1.00

Public attitudes toward depression and help-seeking in four European countries baseline survey prior to the OSPI-Europe intervention. J Affect Disord (2013) 1.00

Heart rate variability and spontaneous baroreflex sequences in supine healthy volunteers subjected to nasal positive airway pressure. J Appl Physiol (1985) (2005) 1.00